Soluble ST2 does not change cardiovascular risk prediction compared to cardiac troponin T in kidney transplant candidates

• Mira T. Keddis ,

  Roles Conceptualization, Formal analysis, Investigation, Methodology, Project administration, Supervision, Writing – original draft, Writing – review & editing

  * E-mail: keddis.mira@mayo.edu

  Affiliation Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Phoenix, Arizona, United States of America

  http://orcid.org/0000-0001-8249-0848

  ⨯
• Ziad El-Zoghby,

  Roles Methodology, Resources, Writing – review & editing

  Affiliation Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Bruce Kaplan,

  Roles Methodology, Supervision, Writing – review & editing

  Affiliation Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Phoenix, Arizona, United States of America

  ⨯
• Jeffrey W. Meeusen,

  Roles Resources, Writing – review & editing

  Affiliation Division of Renal Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Leslie J. Donato,

  Roles Resources

  Affiliation Division of Renal Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Fernando G. Cosio,

  Roles Conceptualization, Supervision, Writing – review & editing

  Affiliation Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• D. Eric Steidley

  Roles Conceptualization, Supervision, Writing – review & editing

  Affiliation Division of Cardiology, Department of Medicine, Mayo Clinic, Phoenix, Arizona, United States of America

  ⨯